Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of concizumab in male participants (Japan)
jRCT2080223625Phase 2Completed
- Start
- Aug 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2 trial of concizumab (2 arms). Started Aug 2017; status: completed.
02
Drugs
concizumab
Beyond the preview
Go deeper on jRCT2080223625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223625.